Endothelial cell apoptosis in angiogenesis and vessel regression

Circulation Research

Volumn 87, Issue 6, 2000, Pages 434-439

  Dimmeler, Stefanie ^a   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cell death; Endothelial cells; Growth factors; Hemodynamic forces

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; APOPTOSIS; ATHEROSCLEROSIS; CANCER THERAPY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; HEMODYNAMICS; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

EID: 0034665071     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.6.434     Document Type: Short Survey

References (68)

1. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
2. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
3. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
4. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
5. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
6. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation
7. A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis
8. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
9. Endothelial apoptosis in Braf-deficient mice
10. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: A link between the apoptosome and the proteasome pathway
11. Posttranscriptional modification of Bcl-2: Molecular characterization of the involved signaling pathways
12. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells
13. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner
14. Role of protein kinase C in the inhibition by fibroblast growth factor of apoptosis in serum-depleted endothelial cells
15. Angiopoietin-1 is an apoptosis survival factor for endothelial cells
16. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway
17. Akt takes center stage in angiogenesis signaling
18. Akt is more than just a Bad kinase
19. Activation of nitric oxide synthase in endothelial cells via Akt-dependent phosphorylation
20. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
21. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases
22. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway
23. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
24. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells
25. Essential role for oncogenic Ras in tumour maintenance
26. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability
27. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
28. Endostatin induces endothelial cell apoptosis
29. Endostatin-induced tyrosine kinase signaling through the shb adaptor protein regulates endothelial cell apoptosis
30. Multiple forms of angiostatin induce apoptosis in endothelial cells
31. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrinbinding motif RGD
32. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells
33. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
34. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
35. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects
36. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent
37. Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow
38. Mechanism of deletion of endothelial cells during regression of the corpus luteum
39. Increase in endothelial cell density before artery enlargement in flowloaded canine carotid artery
40. Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta
41. Shear stress inhibits apoptosis of human endothelial cells
42. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells
43. 2-induced apoptosis of human endothelial cells by modulation of the glutathione redox cycle and nitric oxide synthase
44. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques
45. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: Involvement in suppression of apoptosis
46. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress
47. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
48. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells
49. Effect of diabetes mellitus on formation of coronary collateral vessels
50. Basic fibroblast growth factor reverses atherosclerotic impairment of human coronary angiogenesis-like responses in vitro
51. Oxidized low density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases: A mechanistic clue to the response to injury hypothesis
52. Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells
53. Pro-atherosclerotic factors induce the dephosphorylation of the survival signaling protein kinase Akt
54. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells
55. Phosphorylation of the endothelial nitric oxide synthase at Ser 1177 is required for VEGF-induced endothelial cell migration
56. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt
57. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element
58. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
59. Loss of PTEN facilitates HIF-1-mediated gene expression
60. Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma
61. Endothelial progenitor cells as putative targets for angiostatin
62. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
63. Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors
64. Combined effects of angiostatin and ionizing radiation in antitumour therapy
65. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma
66. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina
67. Development of inflammatory angiogenesis by local stimulation of Fas in vivo
68. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells